Category: Covid-19

This Reporting Protocol provides information for reporting countries’ data managers.

In order to explore how insights from the implementation of non-pharmaceutical interventions (NPIs) during the COVID-19 pandemic may guide further preparedness for COVID-19 – as well as pandemic preparedness and response work in the EU more generally, ECDC organised an expert consultation in June 2022 on the implementation and evaluation of NPIs. This report summarises…

Since the end of October 2022 and as of week 47, several EU/EEA countries have indicated an increase in paediatric hospitalisations due to RSV infections causing bronchiolitis, amidst concurrent circulation of other respiratory pathogens, such as the influenza and SARS-CoV-2 viruses.

In recent weeks, respiratory syncytial virus (RSV) circulation in the EU/EEA has intensified, with increasing transmission rates in all population groups and an earlier-than-usual start of the season. Several EU/EEA countries are experiencing high RSV circulation and the number of severe acute respiratory infections (SARI) due to RSV is increasing. At this time of the…

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 4 – 10 December 2022 and includes updates on COVID-19, Ebola virus, respiratory syncytial virus, streptococcal infection, diphtheria, seasonal influenza, mpox (monkeypox), hepatitis, MERS-CoV, meningitis, and mass gathering monitoring at the FIFA World Cup 2022 Qatar.

From 5th to 7th October 2022, the 8th Joint ECDC/WHO Europe Influenza and COVID-19 Surveillance Meeting was held online.

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 27 November – 3 December 2022 and includes updates on COVID-19, Ebola, diphtheria, respiratory syncytial virus, seasonal influenza, monkeypox, mass gathering monitoring at the FIFA World Cup 2022 Qatar, Chikungunya, dengue, Shigella sonnei, poliomyelitis, meningitis, cholera.

The 2022-2023 influenza (flu) season epidemic is off to an early start in the European region as concerns over Respiratory syncytial virus (RSV) rise and COVID-19 is still being a threat.

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 20 – 26 November 2022 and includes updates on monitoring the FIFA World Cup in Qatar, cholera, COVID-19, diphtheria, Ebola virus disease, polio, Respiratory Syncytial Virus, seasonal influenza, monkeypox, and West Nile virus.

This generic protocol for ECDC studies describes the design and methods for a prospective multi-country cohort study of hospital-based healthcare workers (HCWs) to evaluate the effectiveness of COVID-19 vaccine in preventing laboratory-confirmed SARS-CoV-2 infection.